FMP
Meituan (OTCPK:MPNGY) Faces Financial Strain Amid Competitive Pressures
Meituan (OTCPK:MPNGY), a prominent Chinese shopping-and-delivery platform, recently reported its Q3 2025 earnings. The company, known for its extensive range of services, faces stiff competition from Alibaba's Ele.me and JD.com. Despite its strong market presence, Meituan reported its first loss in nearly three years, highlighting the challenges in maintaining its market share. On November 28, 2025, Meituan reported an earnings per share (EPS) of -0.64924, which was below the estimated EPS of -...
Read MoreCanadian National Railway Company (NYSE:CNI) Stock Upgrade and Q3 Earnings Overview
Canadian National Railway Company (NYSE:CNI) is a major player in the North American rail industry, providing freight transportation services across Canada...
Inspire Medical Systems, Inc. (NYSE: INSP) Faces Class Action Lawsuit Amid Operational Challenges
Inspire Medical Systems, Inc. (NYSE: INSP) is a medical technology company specializing in innovative solutions for sleep apnea. The company is currently e...
Market Trends Reflected in Recent Company Performances
In recent market activity, several companies have experienced significant price movements and trading volumes, highlighting key trends in their sectors. SM...
Earnings Calendar
Earnings Call Transcripts
Stock Gainer
Stock Losers
Most Searched Stocks
Highest Volume
Market News
Evercore ISI Reaffirms CrowdStrike at In Line Ahead of Q3 Results
Evercore ISI reiterated its In Line rating and $430 price target on CrowdStrike Holdings (NASDAQ: CRWD) ahead of the company’s fiscal third-quarter report ...
US Tiger Securities Cuts Li Auto Target After Weak Q3, Maintains Buy
US Tiger Securities lowered its price target on Li Auto (NASDAQ: LI) to $24 from $28, while keeping a Buy rating. The firm cited a soft third quarter in...
Guggenheim Reaffirms Dollar General at Buy, Sees Near-Term Catalysts
Guggenheim reiterated a Buy rating and $125 price target on Dollar General (NYSE: DG). The firm noted that although the shares had significantly outperf...
Netflix (NASDAQ:NFLX) Stock Analysis: A Potential 41.41% Increase in Value
Netflix (NASDAQ:NFLX) is a leading player in the streaming industry, known for its vast library of content and original programming. The company has consis...
Rosenblatt Trims Netflix Price Target After 10-for-1 Stock Split Update
Rosenblatt Securities reduced its price target on Netflix (NASDAQ: NFLX) to $152 from $153, while reiterating a Buy rating. The adjustment stemmed prima...
UBS Lifts Ferrari Price Target, Cites Strength in Long-Term Brand Strategy
UBS raised its price target on Ferrari (NYSE: RACE) to $563 from $554 while maintaining a Buy rating. The firm said Ferrari’s targets at its prior capit...
Evercore ISI Cuts Alexandria Real Estate Price Target Ahead of Investor Day
Evercore ISI lowered its price target on Alexandria Real Estate Equities (NYSE: ARE) to $72 from $74, while reaffirming an Outperform rating. The firm s...
Macy's Inc. (NYSE:M) Faces Challenges but Shows Resilience in Retail Sector
Macy's Inc. (NYSE:M) is a well-known American department store chain, offering a wide range of products from clothing to home goods. The company competes w...
Ferrari (NYSE:RACE) Maintains Strong Position with UBS "Buy" Rating and Raised Price Target
On November 28, 2025, UBS maintained its "Buy" grade for Ferrari (NYSE:RACE), with the action being "hold." At the time of this announcement, the stock pri...
Financial Performance of Mitchells & Butlers PLC (MBPFF)
MBPFF, trading on the OTC exchange, recently reported its earnings, achieving an EPS of $0.1655, slightly above the estimated $0.1653. The company's revenu...
Deere & Company (NYSE: DE) Stock Analysis: A Look at the Future
Deere & Company (NYSE: DE) is a leading manufacturer of agricultural, construction, and forestry machinery. Known for its iconic green and yellow equipment...
Neurocrine Biosciences, Inc. (NASDAQ: NBIX) Maintains Strong Position in Biopharmaceutical Industry
Neurocrine Biosciences, Inc. (NASDAQ: NBIX) is a biopharmaceutical company focused on developing treatments for neurological and endocrine-related disorder...
Vera Therapeutics' Stock Sees Bullish Outlook from Analysts
Vera Therapeutics, trading under the symbol NASDAQ:VERA, is a biopharmaceutical company focused on developing treatments for serious diseases. Recently, H....
Anavex Life Sciences Corp. (NASDAQ: AVXL) Gains Attention for Alzheimer's Drug Development
Anavex Life Sciences Corp. (NASDAQ: AVXL) is a clinical-stage biopharmaceutical company focused on developing treatments for central nervous system disease...
